Clinical trial Recruiting at 1 site Observational Ages 18 to 65

Different IV Fluids After Surgery for Chronic Subdural Hematoma

Official title: The Effect of Dextrose 5% in 0.225% Sodium Chloride (D5 1/4NS) on Postoperative Chronic Subdural Hematoma Size and Recurrence Rate

Run by Carilion Clinic · NCT03831997 · Data updated 2026-11-12

Researchers will test whether giving D5 1/4NS after burr hole drainage helps shrink residual space and lowers recurrence in chronic subdural hematoma patients.

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment35 (estimated)
SponsorCarilion Clinic
Academic / other
Locations1 site (Roanoke, Virginia)
StatusRecruiting
StartedJanuary 17, 2019
Main results expectedJanuary 1, 2030
Study endsJune 1, 2030
Registry record updatedNovember 6, 2026
Trial IDNCT03831997 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults diagnosed with chronic subdural hematoma requiring burr hole drainage and able to tolerate the postoperative fluid plan.

Probably not a fit

Patients with acute hemorrhage, significant electrolyte issues, or other exclusions may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study explores whether postoperative intravenous fluids influence the recurrence of chronic subdural hematoma (CSDH) after burr hole drainage. By administering dextrose 5% in 1/4 normal saline, the study aims to expand brain tissue and reduce the residual cavity, potentially lowering recurrence rates. The trial will compare recurrence risk and remaining hematoma cavity in relation to the fluid strategy and other known risk factors. Outcomes include volume changes on imaging and the need for additional surgery within 3 months or after. The study is conducted at a single center and has no designated control group described.

Why it matters

Potential benefit: If successful, the fluid strategy could reduce CSDH recurrence and the need for subsequent operations.

How similar studies have gone: There is limited prior evidence for this exact fluid strategy in reducing CSDH recurrence; the approach is novel in this context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of chronic subdural hematoma (based on imaging)
* Need for surgical intervention (assessed by attending neurosurgeon based on full neurological assessment)
* The procedure of choice is burr hole drainage
* Cessation of anti-coagulant therapy with accompanying normal lab values in appropriate time frames respective to the drug
* Tolerance of supine position

Exclusion Criteria:

* \<60 years old
* Presence of acute hemorrhage, stroke, or parenchymal damage
* Neurological deficits not accountable to mass effect
* Hyponatremia or inherent electrolyte imbalances
* Pregnancy or non-consentable patients
* Previous neurological surgery up to 1 year before being considered for the study
* Rapid re-expansion of brain observed intraoperatively by attending neurosurgeon
* Congestive heart failure or other medical conditions precluding normal postoperative administration of IV fluids
* Blood glucose levels \> 135 mg/dL

Where it's running

  • Carilion Roanoke Memorial Hospital
    Roanoke, Virginia, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.